On November 19, 2024, Steven Collis, Executive Chairman of Cencora Inc (COR, Financial), sold 21,509 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 306,751.665 shares of the company.
Cencora Inc (COR) is a company engaged in the distribution of pharmaceutical products and services. It provides a range of services to healthcare providers and pharmaceutical manufacturers, including logistics, supply chain management, and consulting services.
Over the past year, Steven Collis has sold a total of 196,939 shares and has not purchased any shares. The insider transaction history for Cencora Inc shows that there have been 1 insider buy and 23 insider sells over the same timeframe.
On the day of the recent sale, shares of Cencora Inc were trading at $242.16, giving the stock a market cap of $48,157.106 million. The company's price-earnings ratio stands at 32.72, which is higher than the industry median of 20.21 and also higher than the company’s historical median price-earnings ratio.
With a trading price of $242.16 and a GF Value of $220.12, Cencora Inc has a price-to-GF-Value ratio of 1.1, indicating that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
